Search

Andy Minn, MD, PhD, will return to Memorial Sloan Kettering Cancer Center (MSK) as the inaugural Chair of MSK’s new Immuno-Oncology Program in August.

… Thursday, May 15, 2025 Andy Minn, MD, PhD, will return to Memorial Sloan Kettering Cancer Center (MSK) as the inaugural Chair of MSK’s new Immuno-Oncology Program in August. This is a full-circle moment for Dr. Minn, a renowned physician-scientist, who completed his postdoctoral training with  Joan Massagué

Several MSK physicians and researchers presenting during the plenary sessions.

… Thursday, April 8, 2021 Thousands of oncology experts from around the world will tune in April 10-15 for the American Association for Cancer Research’s (AACR) Annual Meeting: Week 1 . The meeting is the first of two virtual meetings, with clinical trial plenary sessions, clinical trial poster sessions

A surprising discovery linking the hormone insulin to skin pigmentation offers fresh insights into how animal bodies take shape.

… Thursday, May 24, 2018 Summary Scientists at the Sloan Kettering Institute have made a surprising find about how the hormone insulin contributes to skin pigmentation in fish. The discovery may have implications for human cancer. If you’re a zebra, you want your stripes in order. Come to the savannah

Researchers have created tiny structures called organoids from patients’ prostate tumors. These organoids will allow the study of tumors in greater detail and enable correlation of genetic mutations with drug response.

… Thursday, September 4, 2014 Summary Researchers have created tiny structures called organoids from patients’ prostate tumors. These organoids will allow the study of tumors in greater detail and enable correlation of genetic mutations with drug response. An international team of researchers led by Memorial

Memorial Sloan Kettering Cancer Center (MSK) announces the following awards and appointments.

… Tuesday, January 18, 2022 Memorial Sloan Kettering Cancer Center (MSK) announces the following awards and appointments: Francesca M. Gany Named a 2022 Grant Recipient by Prevent Cancer Foundation Francesca M. Gany Francesca M. Gany, MD, MS , Chief, Immigrant Health and Cancer Disparities Service, was

Along with founding partner Equinox, Cycle for Survival begins its signature team stationary-cycling events this week in New York City. 100% of funds raised go directly to rare cancer research at Memorial Sloan Kettering Cancer Center (MSK).

… Tuesday, March 7, 2023 Cycle for Survival, the movement to beat rare cancers, is launching its annual team stationary-cycling events in 15 locations across the country this weekend in New York City. More than 20,000 riders are expected to participate in person and virtually this March, April, and May

If you've been treated for soft tissue sarcoma, a recurrence may be a big concern for you. Here's what MSK's sarcoma experts think you should know about the disease coming back.

… Tuesday, July 17, 2018 Summary Memorial Sloan Kettering experts share information and tips for people who are worried about soft tissue sarcoma coming back. Fear of the cancer coming back is common among people who’ve recently been treated for soft tissue sarcoma. Most recurrences tend to happen within

Cytoreductive surgery for advanced ovarian cancer is safe in older women, even those who present with frailty.

… Thursday, September 19, 2019 Cytoreductive surgery for advanced ovarian cancer is safe in older women, even those who present with frailty, according to our recent prospective study of 42 patients treated at Memorial Sloan Kettering Cancer Center. Despite a high rate of preoperative impairments, there

Memorial Sloan Kettering Cancer Center (MSK) is now recognized as the first dedicated cancer center in the United States to be designated as a qualified provider-led entity (QPLE) under Medicare’s program for appropriate use criteria (AUC). This designation allows MSK to establish best practice standards for the use of CT scans, MRI, and nuclear medicine imaging from initial screening and diagnosis through all stages of cancer care, including survivorship.

… Tuesday, September 19, 2017 New York, NY - Memorial Sloan Kettering Cancer Center (MSK) has become the first dedicated cancer center in the U.S. to be designated a qualified provider-led entity (QPLE) under the Medicare Appropriate Use Criteria (AUC) program. This designation allows MSK to establish

Joan Massagué, Chair of the Cancer Biology and Genetics Program in the Sloan Kettering Institute, has been named the recipient of two prestigious awards.

… Friday, May 1, 2009 Summary Joan Massagué, Chair of the Cancer Biology and Genetics Program in the Sloan Kettering Institute, has been named the recipient of two prestigious awards. Joan Massagué , Chair of the Cancer Biology and Genetics Program in the Sloan Kettering Institute , has been named the